Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance.
about
Characteristic Variations and Similarities in Biochemical, Molecular, and Functional Properties of Glyoxalases across Prokaryotes and Eukaryotes.Increased DNA dicarbonyl glycation and oxidation markers in patients with type 2 diabetes and link to diabetic nephropathy.Methylglyoxal induces endoplasmic reticulum stress and DNA demethylation in the Keap1 promoter of human lens epithelial cells and age-related cataracts.An ameliorative protocol for the quantification of purine 5',8-cyclo-2'-deoxynucleosides in oxidized DNA.Pathological significance of mitochondrial glycationDicarbonyls and glyoxalase in disease mechanisms and clinical therapeuticsDNA Advanced Glycation End Products (DNA-AGEs) Are Elevated in Urine and Tissue in an Animal Model of Type 2 Diabetes.Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.Protein damage in diabetes and uremia--identifying hotspots of proteome damage where minimal modification is amplified to marked pathophysiological effect.Activity, regulation, copy number and function in the glyoxalase system.Dicarbonyl proteome and genome damage in metabolic and vascular disease.Copy number variation of glyoxalase I.A fluorogenic assay for methylglyoxal.Carbonyl stress and schizophrenia.The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases.A mitochondria-targeted mass spectrometry probe to detect glyoxals: implications for diabetes.Modulation of GLO1 Expression Affects Malignant Properties of Cells.Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samples.Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.Guanine glycation repair by DJ-1/Park7 and its bacterial homologs.Mutagenesis and repair induced by the DNA advanced glycation end product N2-1-(carboxyethyl)-2'-deoxyguanosine in human cells.Dicarbonyl stress in clinical obesity.Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation.Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET).Electronic cigarette: A recent update of its toxic effects on humans.A nuclear-localized rice glyoxalase I enzyme, OsGLYI-8, functions in the detoxification of methylglyoxal in the nucleus.Measurement of glyoxalase activities.Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824).
P2860
Q33624183-66C82D54-F665-4967-9408-98226D6E7E13Q35534535-B009C27E-8F8C-4934-8664-38C3648F76BEQ35542218-E1AF78F5-72C0-4015-8E4F-4F58C560D12FQ35895192-C032E751-A4AE-466B-815B-DD4A0579F9B7Q36072507-B045274D-E269-42C3-89FD-B980E8B86814Q37156152-DBF89E57-E0F6-419B-93C4-3D0DE7367C3DQ37694160-6E811CDB-0BA2-4859-817B-34555C2DBC55Q37729161-163690A6-537B-48B0-9798-FE0A8A51E168Q37812619-363DCDC7-EFD8-4B00-8A75-39C4211C1396Q38197337-332928FC-9672-432C-B757-7641F021A060Q38197339-96D12429-C387-4D52-A799-8C977AF09C23Q38197354-9696E1FC-553A-4BF5-B526-770C2C83D724Q38197363-5BEF957C-760D-4567-B6E2-F2BEF9FC82A1Q38226316-51370899-9C57-4C5A-9F4A-9AF28DC745A2Q38394355-DC5D604B-CF79-40C7-95A4-B49839762DA7Q38647043-18838588-B864-49A1-BAD8-9D8CC138FDE8Q38725125-A0D89DA7-F223-4666-BB6E-C1879F3A9D6FQ38972136-BEFB2C60-3DE7-4933-AC82-857F08D64BC7Q39285661-6A24699C-2B1C-468E-81B7-0DDC1440FFB8Q41412797-C15D01BD-0E0C-4811-9E14-DB3CCDDED2B0Q41789554-D700249E-5A93-48C1-B1A7-00B95F1C0112Q42273415-5DAA71D7-DB90-41C0-A1B9-9FEFE4D67917Q42499319-6433AB3A-FD17-4E03-89D7-EB60BE203303Q47142152-9E1DC0DD-40A3-43AA-8758-EE86F16995ECQ47687520-0D6D7B92-6741-4207-9672-76ECB5CCE4B0Q47852815-561C35B4-FC5A-4CE1-9864-13095C6F334BQ48879660-E727585E-C52B-4F3F-BB2B-41D5DED25A0BQ55116823-02D592F2-A894-4A2D-8F5C-039931ABE196
P2860
Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Imidazopurinones are markers o ...... d tumour multidrug resistance.
@en
Imidazopurinones are markers o ...... d tumour multidrug resistance.
@nl
type
label
Imidazopurinones are markers o ...... d tumour multidrug resistance.
@en
Imidazopurinones are markers o ...... d tumour multidrug resistance.
@nl
prefLabel
Imidazopurinones are markers o ...... d tumour multidrug resistance.
@en
Imidazopurinones are markers o ...... d tumour multidrug resistance.
@nl
P2093
P2860
P50
P356
P1476
Imidazopurinones are markers o ...... d tumour multidrug resistance.
@en
P2093
Brigitte M Winklhofer-Roob
Naila Rabbani
Sahar Waris
Thomas Fleming
Thomas Santarius
P2860
P304
P356
10.1093/NAR/GKQ306
P407
P577
2010-04-30T00:00:00Z